SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

Occidental is drawing attention after a Goldman Sachs upgrade to Buy and a move through chart resistance, with traders also pointing to debt reduction, stronger free-cash-flow prospects and bullish call activity. The reaction is mostly optimistic, though some traders question whether the stock can sustain gains as oil prices and Middle East developments remain volatile.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Positive Phase 3 results for Amgens IMDELLTRAIMFINZI combination in first-line small-cell lung cancer are driving attention, with traders highlighting the reported survival benefit and potential to strengthen the drugs growth prospects. The discussion is broadly bullish and also includes anticipation around upcoming earnings and other pipeline updates.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirm is drawing attention ahead of its upcoming earnings report, with traders weighing expectations for slower growth against continued expansion in revenue and gross merchandise volume. Options activity has leaned toward puts, while the community is split between optimism about the business and concern about the growth outlook, consumer credit and insider selling.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVies quarterly earnings beat and raised outlook, supported by growth in Skyrizi and Rinvoq, are driving attention. Traders are encouraged by the immunology portfolios momentum, while others warn of profit-taking after the stocks strong run-up.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is drawing attention after a sharp volatility-linked move, with traders pointing to a VIX spike and backwardation amid market jitters around oil, interest rates, and geopolitical risk. Some see it as a hedge against a broader selloff, while others caution that the leveraged fund can lose value through decay and may not track volatility moves as expected.

Vermilion Energy, Inc. engages in the acquisition, exploration, development, and production of oil and natural gas. It operates through the following geographical segments: Canada, United States of America, France, Netherlands, Germany, Ireland, Australia, and Corporate. The company was founded by Lorenzo Donadeo and Claudio A. Ghersinich in 1994 and is headquartered in Calgary, Canada.

Vermilion Energy Inc

Traders are focused on Middle East-related energy supply disruptions, including reported damage to Gulf LNG facilities, and rising European gas and oil prices; they see Vermilions European gas exposure as a potential beneficiary. Optimism is tempered by debate over whether elevated prices will persist, as well as profit-taking and concern that easing tensions could reverse the move.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is under pressure after Piper Sandler cut its price target, citing concerns that networking growth may be peaking and valuations could come under pressure. Traders are debating whether the selloff is an overreaction given AI-networking demand, while many express frustration with the stocks persistent weakness.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinias third-quarter results, including continued LUPKYNIS sales growth and higher full-year revenue guidance, are driving discussion. While some investors view the report as solid execution, others are frustrated that the stock fell despite the results and that management did not hold an earnings call; patent-litigation developments and pipeline updates are also recurring topics.

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,559,996,383.70523. The last known price of Dogecoin is 0.07552377 USD and is down -0.48 over the last 24 hours. It is currently trading on 1543 active market(s) with $337,365,256.17 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

Dogecoin is drawing attention for its weak, choppy trading around the 8-cent level, with traders watching nearby support and resistance as broader crypto-market softness weighs on sentiment. Some are buying the dip and holding for a rebound, while others point to persistent declines and worry about further downside.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to a 52-week high has intensified buyout speculation, with traders also pointing to bullish call activity and heavy short interest as possible fuel for a squeeze. Others focus on upcoming BRIUMVI sales and guidance, plus the subcutaneous Phase 3 readout, while cautioning that a takeover remains unconfirmed.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SPCX Stock Up Nearly 10% Since IPO — Analyst Sees 82% Upside Without Tesla Merger, Even If Revenue Misses Lofty Goals 

Equity

Bernstein forecasts $424 billion in 2028 revenue, below SpaceX’s own growth ambitions.

SpaceX Shoots Up Post Q3: Is More Upside Ahead for SPCX ETF?

SpaceX's strong Q3 results, surging AI revenue and upbeat 2027 outlook put these SpaceX-focused ETFs on investors' radar.

SpaceX Surges on Solid Q3 Beat & Upbeat Outlook: ETFs to Tap

TSLA, SPCX Eye Green Open: Gary Black Predicts $420 SpaceX Buyout Of Tesla — Sees Announcement In ‘Next Few Weeks’ 

Gene Munster also interpreted the Roadster showcase as another sign of Musk’s desire to combine Tesla and SpaceX.

SpaceX’s Debut Quarter Fails To Lift Off: Short Seller Chanos Flags Starship Forecast Cut — But Wall Street Still Sees Big Upside

Musk moved from targeting at least daily flights around August 2027 to weekly or twice-weekly launches next year.

SPCX Stock Slides Overnight: Musk Maps Falcon Wind-Down For Starship — Rare ‘Sell’ Call Sees 27% Downside

 Falcon’s retirement could worsen a global launch-capacity shortage as rivals struggle to scale.

SpaceX Stock Rises Overnight: Elon Musk’s Stake Tops $900B — But Billions In Shares Still Depend On ‘Extremely Crazy Good’ Outcomes 

Some vesting targets involve multitrillion-dollar valuations, space-based computing and a million-person Mars settlement.

Here's What You Need to Know About SpaceX Investing & ETFs

SpaceX's strong rebound, institutional interest and AI ambitions have renewed investor optimism. Here's a guide to SpaceX-focused ETFs.

SPCX Stock Eyes Another Green Week: Analyst Warns Traders To ‘Divorce’ SpaceX Rally From Fundamentals

Morningstar maintained its $62 fair-value estimate, implying about 58% downside, and rates SPCX stock one star.

SpaceX Stock Slips Overnight After 3-Day Rally — Here's Why Ron Baron Sees 40x Upside And ‘Hundreds Of Billions’ In Gains

Baron Capital’s $3 billion SpaceX investment was worth about $25 billion in June, and the firm wants to invest another $1 billion.

ProShares Trust - ProShares Ultra SpaceX ETF

Bullish Sentiment

<ul class="summary-bullets"><li>The firm expects terrestrial computing capacity to reach 13 gigawatts in 2027 and 20 gigawatts in 2028.</li><li>SpaceX expects fourth-quarter capex of $35 billion to $40 billion and reports compute payback periods under a year.</li><li>Bernstein’s model assumes neither a Tesla merger nor a telecom-tower deal.</li></ul>Shares of Space Exploration Technologies Corp. (SPCX) have gained nearly 10% from their IPO offer price, but Bernstein SocGen Group sees room for a much bigger rally — even without assuming a Tesla merger or SpaceX reaching its full revenue ambitions.<a href="https://stocktwits.com/symbol/SPCX">SPCX shares</a> slipped about 0.4% on Monday, leaving them 9% above their $135 IPO offer price.<h2 class="st-heading-2">Bernstein Raises Stakes On SpaceX</h2>The research firm raised its price target to $268 from $248, implying an 82% upside from current levels, and maintained an ‘Outperform’ rating. “We raise our SpaceX outlook primarily on terrestrial AI build plans. We believe the case for a multi-trillion dollar valuation rests on success of orbital data centers,” the firm said.Bernstein said computing infrastructure on Earth adds materially to SpaceX’s revenue outlook, while its enterprise and government connectivity business also appears to be outperforming.The firm now forecasts $424 billion in full-year 2028 revenue. That remains below SpaceX’s ambition to reach an annualized revenue pace of $500 billion to $1 trillion by the end of 2027, although Bernstein raised its estimate.The company’s goal refers to its revenue pace exiting 2027, rather than total sales during that year. “And, as we have said, you do not need to go all the way to the company’s plan to make SpaceX attractive,” the firm said.Bernstein also noted that SpaceX is planning its first orbital data-center launches in late 2027, with operations beginning in mid-2028. Flight 15 is expected within weeks, with SpaceX planning to catch both the booster and the ship. Bernstein said the heat shield’s performance on Flight 14 could set up the first Starship reuse on Flight 16. “Reusability is key to making orbital data centers successful,” the firm said.<h2 class="st-heading-2">Bigger Capacity Plans Leave Room For More SPCX Upside</h2>Bernstein sees SpaceX’s terrestrial computing capacity reaching 13 gigawatts by the end of 2027 — five gigawatts above its previous forecast — before climbing to 20 gigawatts in 2028.This would mark a sharp jump from the 1.7 gigawatts SpaceX reported at the end of September. On the recent earnings call, Musk said he was confident the company could add 10 gigawatts in 2027, on top of the 2.5 gigawatts to 3 gigawatts expected online by the end of this year.Additionally, Bernstein said the company’s comments pointed to compute prices above the $30 to $50 per watt level seen in recent deals. The firm raised its pricing assumptions but left them below the company’s expectations, leaving room for further gains.“If the company achieves its pricing expectations, there could be more upside, both for terrestrial and orbital,” Bernstein said.<h2 class="st-heading-2">SpaceX’s AI Spending Comes With A Payback Pitch</h2>Bernstein estimates capex of about $35 billion per gigawatt as SpaceX expands capacity. The company’s earnings call underscored the scale of the spending. CFO Bret Johnsen said Q3 capex totaled $19.6 billion and forecast another $35 billion to $40 billion in the fourth quarter.The company also pointed to strong returns on the new infrastructure. “At current pricing, new compute deployments are generating a payback of less than a year,” Johnsen said. SpaceX’s superintelligence segment generated $7.6 billion in third-quarter revenue, making it the company’s largest revenue segment.<h2 class="st-heading-2">Bernstein’s Bull Case Needs No Tesla Merger</h2>Bernstein’s model includes neither a potential Tesla merger nor a reported telecom-tower deal. “Elon talked of a possible Tesla merger and SpaceX is reportedly discussing a telco tower deal,” the firm said. “We make no assumptions on either here.”Separately, ARK Investment Management&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/cathie-wood-tesla-spacex-gdp-growth-ark-merger-win-both-shareholders/cZUIApgRBzQ">said</a> that combining the companies could allow Tesla’s potential robotaxi cash generation to help fund SpaceX’s expansion. Its no-premium share-swap scenario projected a 3.8-fold increase in returns for Tesla shareholders and a 7.2-fold increase in incremental returns for SpaceX investors.Musk, however, has cautioned that a transaction remains uncertain. Independent board committees, excluding him because of his conflict of interest, have not agreed on terms. “I think some people out there assume that a SpaceX and Tesla merger is a certainty, and I think that would be overstating it,” he said.<h2 class="st-heading-2">How Do Retail Traders Feel About SPCX?</h2>On Stocktwits, retail sentiment for SPCX slipped to ‘bullish’ from ‘extremely bullish’ levels a week ago amid a 206% surge in 24-hour message volumes.<figure class="image"><img src="https://news.stocktwits-cdn.com/spcx_ss_8873c8e24f.png" alt="spcx ss.png" width="637" height="336"><figcaption>SPCX sentiment and message volume as of October 27 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/Crabber/message/667373833">said</a>, “$SPCX this is gonna be 100% within a year and 10 times in five it’s kind of buying Tesla in 2019”<stembedurl>https://stocktwits.com/Crabber/message/667373833</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/trumpdisasterprez/message/667378491">said</a>, “$SPCX Notice the lack of enthusiasm here for buying a failing car company with YOUR money. The good news is it will never happen. The bad news is Elon will keep this rumor going for years to prop up Tesler.”<stembedurl>https://stocktwits.com/trumpdisasterprez/message/667378491</stembedurl>For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/michael-burry-anthropic-ipo-filing-ai-bear-case-financial-risks-beyond-tech/cZUIx7dRBzZ">Michael Burry Says Anthropic’s IPO Filing Changes Nothing About His AI Bear Case — Flags Financial Risks Beyond The Tech&nbsp;</a>

Elon Musk waves as he arrives for a state dinner at the Lusail Palace on May 14, 2025, in Doha, Qatar. (Photo by Win McNamee/Getty Images)

SPCX Stock Up Nearly 10% Since IPO — Analyst Sees 82% Upside Without Tesla Merger, Even If Revenue Misses Lofty Goals

Leverage Shares 2x Long SPCX Daily ETF

Defiance Daily 2X Space ETF

Tradr 2X Long SpaceX Daily ETF

SpaceX

Direxion Daily TSLA Bull 2X Shares

T-REX 2X Long Tesla Daily Target ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

SPCF ProShares Trust - ProShares Ultra SpaceX ETF

Fundamentals

Latest SPCF News